Blackstone has acquired a 60% stake in CMIC Co, a Japanese contract research firm that helps drug companies run clinical trials, according to a company release.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
